Bloomberg: Trump’s FDA Chief Takes Wide Aim at Opioid Addiction Crisis

Bloomberg: Trump’s FDA Chief Takes Wide Aim at Opioid Addiction Crisis

Gottlieb said he wants to examine whether insurers and pharmacy benefit managers, or PBMs, can reduce the number of pills dispensed. That could involve changing drug labels or requiring doctor education for longer prescriptions.